Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML)
Handle using appropriate laboratory safety procedures and personal protective equipment.
The peptide's natural origin in gastric secretions suggests inherent biocompatibility with human physiology
Pattern Higher research planning Typical Range 200-300 mcg Route SubQ Notes Used in some research write-ups
US$ 27.31
US$ 28.40
US$ 24.00
